|1||NCT01088763||Terminated||Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia||
||129||All||1 Year to 21 Years (Child, Adult)||NCT01088763||NCI-2011-02024
|March 2010||May 2011||May 2011||March 17, 2010||November 5, 2014||
|2||NCT00601289||Withdrawn||Temozolomide in Treating Patients With Invasive Pituitary Tumors||
||Other / NIH||
||0||All||18 Years to 75 Years (Adult, Older Adult)||NCT00601289||CDR0000577534
|December 2009||October 2010||January 28, 2008||July 31, 2012|
† Study has passed its completion date and status has not been verified in more than two years.